The effects of portal shunts on intestinal cytochrome P450 3A activity - Reply

被引：4
作者：
Chalasani, N [1 ]
Gorski, JC
Patel, NH
Hall, SD
Galinsky, RE
机构：
[1] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Radiol, Indianapolis, IN USA
[3] Purdue Univ, Sch Pharm, W Lafayette, IN 47907 USA
来源：
HEPATOLOGY | 2002年 / 35卷 / 06期
关键词：
D O I：
10.1053/jhep.2002.33827
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1550 / 1551
页数：2
相关论文
共 7 条
  • [1] Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: Effects of transjugular intrahepatic portosystemic shunts
    Chalasani, N
    Gorski, JC
    Patel, NH
    Hall, SD
    Galinsky, RE
    [J]. HEPATOLOGY, 2001, 34 (06) : 1103 - 1108
  • [2] The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin
    Gorski, JC
    Jones, DR
    Haehner-Daniels, BD
    Hamman, MA
    O'Mara, EM
    Hall, SD
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (02) : 133 - 143
  • [3] Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt
    Huonker, M
    Schumacher, YO
    Ochs, A
    Sorichter, S
    Keul, J
    Rössle, M
    [J]. GUT, 1999, 44 (05) : 743 - 748
  • [4] Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression
    Lown, KS
    Bailey, DG
    Fontana, RJ
    Janardan, SK
    Adair, CH
    Fortlage, LA
    Brown, MB
    Guo, WS
    Watkins, PB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) : 2545 - 2553
  • [5] CONCEPTS BASIC TO PHARMACOKINETICS
    TOZER, TN
    [J]. PHARMACOLOGY & THERAPEUTICS, 1981, 12 (01) : 109 - 131
  • [6] Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics
    Wacher, VJ
    Silverman, JA
    Zhang, YC
    Benet, LZ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (11) : 1322 - 1330
  • [7] YANG JS, 2001, BR J CLIN PHARM, V52, pP472
1